Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

Although there are several effective anti-osteoporosis drugs on the market today, new therapies with improved safety profiles and efficacy are still needed. The FDA called osteoporosis-related ...

Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic ...

A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer ...

Scientists at Pompeu Fabra University (UPF) have made a great leap forward in predicting the risk of hip fracture among women ...

New evidence suggests that the risk for fracture increases within months of low-dose prednisone, challenging the idea of a ...

FDA has qualified the first surrogate endpoint for bone fractures in anti-osteoporosis drug trials for at-risk ...

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...